A detailed history of Kbc Group Nv transactions in Natera, Inc. stock. As of the latest transaction made, Kbc Group Nv holds 15,607 shares of NTRA stock, worth $2.39 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,607
Previous 27,551 43.35%
Holding current value
$2.39 Million
Previous $4.36 Million 49.39%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 25, 2025

SELL
$132.63 - $177.0 $1.58 Million - $2.11 Million
-11,944 Reduced 43.35%
15,607 $2.21 Million
Q4 2024

Jan 22, 2025

BUY
$117.67 - $174.0 $2.86 Million - $4.23 Million
24,324 Added 753.77%
27,551 $4.36 Million
Q3 2024

Nov 06, 2024

BUY
$97.75 - $129.67 $42,912 - $56,925
439 Added 15.75%
3,227 $410,000
Q2 2024

Jul 17, 2024

BUY
$85.28 - $112.6 $19,529 - $25,785
229 Added 8.95%
2,788 $302,000
Q1 2024

May 08, 2024

BUY
$59.21 - $92.9 $18,473 - $28,984
312 Added 13.89%
2,559 $234,000
Q4 2023

Feb 13, 2024

BUY
$37.55 - $62.64 $84,374 - $140,752
2,247 New
2,247 $141,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $14.8B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.